Our Causes
30 THOUSAND FEET FROM GENETICS
- Advancement in Genetics has introduced an opportunity for binary analysis of predisposed growth and evolution from the time of conception
- Currently our technology enables us to associate common genetic markers (SNPs) with populations affected by a specific pathology.
- However the magnitude or quantitative value of findings is limited by the sample size from which that corollary finding is derived.
- In addition, the downstream impacts of genetic pre-cursors are subject to a myriad of epigenetic factors that are not actively tracked and related back to those same patient populations.
- This presents a challenge with specific scientific certainty as we must still rely on statistics and probability to make any predictions.
Make a Donation
Make a Donation
RETROVIRUSES, EVOLUTION AND PATHOLOGY
- We don’t know with any definitive certainty the extent to which retroviruses contributed to our evolution or present pathologies.
- But we do know there enough data points to warrant significant investigation.
- SNPs don’t tell the whole story
- While convenient markers that do account for many functions enabled by our DNA the nature or origin of those SNPs cannot be entirely ascertained without much more data analysis
- How can we begin to target therapies based on predicted susceptible patient populations?
Up-Coming Initiatives
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.